
mRNAã¯ã¯ãã³ãªããŠãã®ã¯ååšããªããã¯ã¯ãã³ãšåŒã¶ãªã
å èšäºã¯ãã¡ã/Original article here
ç¬¬äºæ¬¡äžç倧æŠäžã®ããã³ãŒã¹ãã§ã¯ãäœçŸäžäººãã®çœªã®ãªã倧人ãåäŸããåé¯ããæ®é ·ãªå®éšã«ãããããæ®ºå®³ãããŸãããããã¯ããšãŒãããåå°ã®èªæ²»äœè·å¡ãå ¬åå¡ãã仲éã®åžæ°ã®æ®ºå®³ãåãã§å©ããåæã«åœŒãã®å¶æªãªè¡çºã圌ããåŸã£ãŠããæŽåãæè·ããŠããããã§ãã
æŽåã®æ®èè¡çºããèªåãã¡ã¯å®å šã ãšä¿¡ããŠããä»ã®å°å瀟äŒã®äººã ã¯ãæ¿åºãå°å瀟äŒã®ãªãŒããŒã«å¯ŸããŠå£°ãäžããããšãæããç¡é¢å¿ã§ããããªãã£ãã®ã§ãã
èŠèŠãã¯ãããŸãããïŒ
æãåœã®æŽå²äžæãéªæªãªç¯çœªããä»ãŸãã«ãç§ãã¡ã®ç®ã®åã§è¡ãããŠããã®ã§ããã¢ã¡ãªã«ã®å€§äººãšçœªã®ãªãåäŸãã¡ãå·ã€ããé害ãè² ããæ®ºãããŠããŸããããã¯ããã³ããã19ã¯ã¯ãã³ããšããåç®ã§ãmRNAæè¡ã®çç©å µåšã泚å°ããããšããäžçèŠæš¡ã®å¶æªãªå®éšã«ãå¿ççã«æããã匷å¶çã«åå ãããããçµæãªã®ã§ãã
mRNAã¯ã¯ãã³ãªããŠãã®ã¯ååšããŸãããmRNAã¯éºäŒåç·šéæè¡ã®äžéšã§ãããåžžã«ããã§ãã£ããéºäŒåç·šéæè¡ã¯ããŠã€ã«ã¹ãæ€ç©ããã€ããªããå¯çè«ãåç©ãªã©ã®æ°çš®ã®çºæãèªå·±å ç«çŸæ£ã®äœæãçã®çºçãè»äºçšçç©å µåšã®éçºãªã©ã«å©çšãããŠããŸãã
mRNAéºäŒåç·šéæè¡ã¯40幎以äžã«ããã£ãŠç ç©¶éçºãããäŒæ¥ãäœåºŠãç Žç£ã«è¿œã蟌ã¿ãã³ããã19以åã®äœç©ã«ãFDAã®èªå¯ãåããããšããããŸããããªããªãã人éã®å¥åº·ã«äœã®åœ¹ã«ãç«ãããå®³ãæªæãæ»ãããããã ãã ããã§ãã
18 USC 175ã«ããã°ãmRNAãã¯ãããžãŒã¯æåéãçç©å µåšã®äžçš®ã§ããã
çç©å µåšãšã¯ãäºé²ãŸãã¯é²è·ç®çãåæã®ç ç©¶ããã®ä»ã®å¹³åçç®çã«ãã£ãŠåççã«æ£åœåãããªãçç©å€ïŒmRNAïŒãæ¯çŽ ïŒWIVã¹ãã€ã¯S-2PïŒã鿬ã·ã¹ãã ïŒããã€ã¹ïŒLNPïŒã¯ã¯ãã³ïŒã®ããšã§ããã
mRNAæè¡ã¯ãéºäŒåç·šéæè¡ã§ããéºäŒåå€ç°ãèªçºããç®çã§äœ¿çšããããšãã§ãããNIHã«ãããšãåäŸã®åå äžæã®çªç¶æ»ã®åå ã¯ãéºäŒåã®å€ç°ã§èª¬æã§ããããã§ããå ·äœçã«ã¯ããç ç©¶è ãã¡ã¯ãçªç¶æ»ã®åŒãéãšãªãå¿èãçºäœã®é害ã«é¢é£ãã137ã®éºäŒåã«æ³šç®ããŸãããã

ç§ãã¡æ¿åºã®å»çæ åœè ãmRNAãã¯ãããžãŒã®æ¥çãªãŒããŒã¯ãåäŸãè¥è ãå€§èŠæš¡ãªå¿èã®ççãçºäœãçªç¶æ»ã«èŠããã§ããããšã«é©ããé ããªãã§ããŸãããããã¯éåžžã«æãããããšã§ãããmRNAãã¯ãããžãŒã®å¹æãšããŠã¯ããç¥ãããŠããŸãããã®ãããmRNAãã¯ãããžãŒã¯40幎以äžã®æŽå²ã®äžã§ãäžåºŠã人éãžã®äœ¿çšãFDAã«æ¿èªãããããšããªãã®ã§ãã
mRNA泚å°ãçç©å µåšãããã¯å€§éç Žå£å µåšïŒWMDïŒãšåŒã¶ã®ã¯æ§ããŸããããã¯ã¯ãã³ãšåŒã¶ã®ã¯æ¢ããŠãã ãããmRNA泚å°ã¯ç æ°ãäºé²ããªãããããããšããªããã³ãã19泚å°ã¯ç æ°ãéå®³ãæ»ãåŒãèµ·ããããã«èšèšãããŠããŸãããã¡ã€ã¶ãŒãã¢ãã«ããJ&JãHHSãFDAãCDCãNIHããããŠãã¹ãŠã®æ¿åºé¢ä¿è ãæ¿åºã®å»çå°éå®¶ã¯ãããç¥ã£ãŠããã®ã§ãã

[泚ïŒäžãäžãå ¬éãããªããªã£ãå Žåã§ãä¿åã§ãããããäžã®ç»åãå«ããã¬ãŒã³ããŒã·ã§ã³ã®ã³ããŒãããŠã³ããŒãããäžã«æ·»ä»ããŸãã] ã
眪ã®ãªãåäŸãã¡ãæ»ã«ãåŠå©Šã¯èå ã§èµ€ãåãæ®ºãããããã®ã¹ããŒãéžæã¯ãã£ãŒã«ãã§å¿èçºäœãèµ·ãããæ°éèªç©ºäŒç€Ÿã®ãã€ãããã¯é£è¡äžã«æ©èœäžå šã«é¥ãããããŠæ»ã«ãè¥ãæäººã¯ã¢ã¡ãªã«å šåã§èº«äœé害è ã«ãªã£ããçªç¶æ»ãããããŠããã®ã§ããmRNA泚å°ã«ããæªæãç æ°ãæ»ã¯å¯äœçšã§ã¯ãããŸãããå 端æè¡ã®çç©å µåšãæå³ããçµæãªã®ã§ãã
ä¿¡é Œã§ããå°éå®¶ãã¡ã¯ãã³ããã19ã®mRNAã¯ã¯ãã³ãããã«ã¯ã¯ãã³ã®å®çŸ©ãæºãããŠããªããããããŠããããçç©å µåšã®æŠåšã§ããããšããã€æç¢ºã«èª¬æããææžåããã®ã§ããããïŒ
mRNA泚å°ãçç©å µåšã§ã¯ãªããã³ããã-19ã¯ã¯ãã³ããšåŒã¶ããšã§ãç§ãã¡ã¯ç¯çœªè ãå®ã£ãŠããã®ã§ãã ç¯çœªè ã®è²¬ä»»ã远åããããã«ã¯ãç§ãã¡ãšä¿¡é Œã§ããå°éå®¶ããã³ããã19 mRNA泚å°ãããã«ã¯ã¯ãã³ã®å®çŸ©ã«åèŽãããçç©å µåšã§ããããæç¢ºã«èª¬æããææžåããããšãéèŠã§ãã
Intended Consequencesã¯ããã®æå§ããšããŠæé©ãªå Žæã§ãã